Moderna Reports 8-Fold Jump In Antibodies With Updated Spikevax

2 weeks ago

Moderna Inc. (NASDAQ:MRNA) on Tuesday released preliminary immunogenicity data for the 2025-2026 formula of Spikevax, which targets the LP.8.1 …